Board Change • May 20
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Executive Chairman Kyriakos Sarantis was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Duyuru • Mar 13
Gr. Sarantis S.A. announces Annual dividend, payable on May 08, 2026 Gr. Sarantis S.A. announced Annual dividend of EUR 0.3925 per share payable on May 08, 2026, ex-date on May 04, 2026 and record date on May 05, 2026. Duyuru • Mar 13
Gr. Sarantis S.A. announces Annual dividend, payable on May 09, 2025 Gr. Sarantis S.A. announced Annual dividend of EUR 0.2992 per share payable on May 09, 2025, ex-date on May 02, 2025 and record date on May 05, 2025. Duyuru • Feb 19
Gr. Sarantis S.A. to Report Fiscal Year 2024 Results on Mar 12, 2025 Gr. Sarantis S.A. announced that they will report fiscal year 2024 results After-Market on Mar 12, 2025 Duyuru • Feb 04
Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025 Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025. Recent Insider Transactions • Sep 26
Executive Chairman recently bought €544k worth of stock On the 23rd of September, Kyriakos Sarantis bought around 50k shares on-market at roughly €10.88 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.1m worth in shares. Reported Earnings • Sep 06
First half 2024 earnings released: EPS: €0.38 (vs €0.29 in 1H 2023) First half 2024 results: EPS: €0.38 (up from €0.29 in 1H 2023). Revenue: €302.6m (up 30% from 1H 2023). Net income: €24.3m (up 27% from 1H 2023). Profit margin: 8.0% (down from 8.3% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 6% per year. Buy Or Sell Opportunity • Jul 22
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.7% to €10.88. The fair value is estimated to be €13.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period. Recent Insider Transactions • Jul 10
Executive Chairman recently bought €110k worth of stock On the 4th of July, Kyriakos Sarantis bought around 10k shares on-market at roughly €11.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.0m worth in shares. Buy Or Sell Opportunity • Jul 01
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.9% to €10.68. The fair value is estimated to be €13.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period. Buy Or Sell Opportunity • Jun 12
Now 21% undervalued Over the last 90 days, the stock has risen 4.8% to €10.98. The fair value is estimated to be €13.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.5% per annum. Earnings are also forecast to grow by 12% per annum over the same time period. Declared Dividend • Apr 26
Dividend increased to €0.22 Dividend of €0.22 is 50% higher than last year. Ex-date: 2nd May 2024 Payment date: 13th May 2024 Dividend yield will be 1.9%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (38% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 38% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €11.00, the stock trades at a trailing P/E ratio of 19.4x. Average forward P/E is 20x in the Personal Products industry in Europe. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.96 per share. Buy Or Sell Opportunity • Mar 12
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 21% to €9.62. The fair value is estimated to be €7.92, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. Reported Earnings • Mar 12
Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022) Full year 2023 results: EPS: €0.59 (up from €0.39 in FY 2022). Revenue: €482.2m (up 8.3% from FY 2022). Net income: €39.3m (up 50% from FY 2022). Profit margin: 8.2% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year. Duyuru • Mar 01
Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024 Gr. Sarantis S.A. announced that they will report fiscal year 2023 results on Mar 11, 2024 Duyuru • Dec 01
Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023 Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023, at 15:00 E. Europe Standard Time. Location: 26 AMAROUSSIOU-HALANDRIOU STR. 151 25 MAROUSI Marousi Greece Duyuru • Nov 01
Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023 Gr. Sarantis S.A. announced that they will report nine months, 2023 results on Nov 07, 2023 New Risk • Oct 26
New major risk - Revenue and earnings growth Earnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (3.7% increase in shares outstanding). Reported Earnings • Sep 14
First half 2023 earnings released: EPS: €0.29 (vs €0.17 in 1H 2022) First half 2023 results: EPS: €0.29 (up from €0.17 in 1H 2022). Revenue: €232.4m (up 9.2% from 1H 2022). Net income: €19.2m (up 66% from 1H 2022). Profit margin: 8.3% (up from 5.4% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Duyuru • Aug 29
Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023 Gr. Sarantis S.A. announced that they will report first half, 2023 results on Sep 11, 2023 New Risk • Aug 09
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (4.4% increase in shares outstanding). Reported Earnings • Mar 29
Full year 2022 earnings released Full year 2022 results: Revenue: €445.1m (up 9.0% from FY 2021). Net income: €26.3m (down 35% from FY 2021). Profit margin: 5.9% (down from 9.9% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Sep 11
First half 2022 earnings released: EPS: €0.17 (vs €0.22 in 1H 2021) First half 2022 results: EPS: €0.17 (down from €0.22 in 1H 2021). Revenue: €213.5m (up 9.3% from 1H 2021). Net income: €11.6m (down 21% from 1H 2021). Profit margin: 5.4% (down from 7.5% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Duyuru • Aug 25
Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022 Gr. Sarantis S.A. announced that they will report first half, 2022 results on Sep 08, 2022 Reported Earnings • May 05
Full year 2021 earnings released: EPS: €0.60 (vs €0.58 in FY 2020) Full year 2021 results: EPS: €0.60 (up from €0.58 in FY 2020). Revenue: €408.2m (up 3.8% from FY 2020). Net income: €40.3m (up 4.0% from FY 2020). Profit margin: 9.9% (in line with FY 2020). Over the next year, revenue is forecast to grow 9.0%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Duyuru • Apr 12
Gr. Sarantis S.A., Annual General Meeting, May 24, 2022 Gr. Sarantis S.A., Annual General Meeting, May 24, 2022. Duyuru • Apr 05
Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022 Gr. Sarantis S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022 Recent Insider Transactions • Mar 30
CEO & Director recently sold €2.0m worth of stock On the 23rd of March, Kyriakos Sarantis sold around 265k shares on-market at roughly €7.50 per share. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.2m worth of shares. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 15% share price gain to €7.35, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 27x in the Personal Products industry in Europe. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.65 per share. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €7.01, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 28x in the Personal Products industry in Europe. Total returns to shareholders of 3.8% over the past three years. Board Change • Jan 28
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Recent Insider Transactions • Dec 10
Vice Chairman & CEO recently bought €86k worth of stock On the 1st of December, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.61 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.4m worth in shares. Duyuru • Dec 05
Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million. Gr. Sarantis S.A. (ATSE:SAR) commences share repurchases on December 2, 2021, under the program mandated by the shareholders in the Extraordinary Shareholders Meeting held on September 2, 2020. As per the mandate, the company is authorized to repurchase up to 4,222,844 shares representing 6.04% of the company's outstanding shares after excluding treasury shares for a total of €63.34 million. The maximum buy back price will be at €15 per share and the minimum is €0.78 per share. The purpose of the program is to serve the objectives and uses permitted by law from time to time, which today include share capital reduction, settlement of obligations arising by convertible securities or employee stock options as well as the purposes of future acquisition of another company’s shares. The repurchase program will be valid for 24 months, until September 2, 2022. Recent Insider Transactions • Nov 10
Vice Chairman & CEO recently bought €119k worth of stock On the 5th of November, Kyriakos Sarantis bought around 14k shares on-market at roughly €8.63 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.2m worth in shares. Recent Insider Transactions • Oct 27
Vice Chairman & CEO recently bought €248k worth of stock On the 20th of October, Kyriakos Sarantis bought around 28k shares on-market at roughly €8.78 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.0m worth in shares. Reported Earnings • Sep 11
First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €195.2m (up 6.3% from 1H 2020). Net income: €19.5m (up 25% from 1H 2020). Profit margin: 10.0% (up from 8.5% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year. Recent Insider Transactions • Jul 15
Vice Chairman & CEO recently bought €61k worth of stock On the 8th of July, Kyriakos Sarantis bought around 7k shares on-market at roughly €8.78 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares. Recent Insider Transactions • Jun 12
Vice Chairman & CEO recently bought €90k worth of stock On the 7th of June, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.80 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares. Recent Insider Transactions • Jun 02
Vice Chairman & CEO recently bought €915k worth of stock On the 26th of May, Kyriakos Sarantis bought around 105k shares on-market at roughly €8.71 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.8m worth in shares. Recent Insider Transactions • May 23
Vice Chairman & CEO recently bought €69k worth of stock On the 18th of May, Kyriakos Sarantis bought around 8k shares on-market at roughly €8.75 per share. In the last 3 months, they made an even bigger purchase worth €217k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.0m worth in shares. Recent Insider Transactions • May 08
Vice Chairman & CEO recently bought €217k worth of stock On the 5th of May, Kyriakos Sarantis bought around 24k shares on-market at roughly €8.88 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.6m worth in shares. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €393.4m (up 6.3% from FY 2019). Net income: €38.7m (up 1.9% from FY 2019). Profit margin: 9.8% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Duyuru • Mar 06
Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021 Gr. Sarantis S.A. announced that they will report fiscal year 2020 results After-Market on Apr 08, 2021 Recent Insider Transactions • Mar 05
Vice Chairman & CEO recently bought €96k worth of stock On the 25th of February, Kyriakos Sarantis bought around 11k shares on-market at roughly €9.05 per share. In the last 3 months, they made an even bigger purchase worth €118k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares. Recent Insider Transactions • Feb 13
Vice Chairman & CEO recently bought €118k worth of stock On the 5th of February, Kyriakos Sarantis bought around 13k shares on-market at roughly €8.85 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares. Is New 90 Day High Low • Jan 05
New 90-day high: €9.27 The company is up 5.0% from its price of €8.84 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.26 per share. Recent Insider Transactions • Dec 16
Vice Chairman & CEO recently bought €51k worth of stock On the 10th of December, Kyriakos Sarantis bought around 6k shares on-market at roughly €8.74 per share. In the last 3 months, they made an even bigger purchase worth €69k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €474k worth in shares. Duyuru • Sep 22
Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis. Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis on September 28, 2006. Duyuru • Sep 06
Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020 Gr. Sarantis S.A. is not provide financial guidance for the fiscal year of 2020 as it is not able to make accurate predictions at the time due to the continuing high uncertainty regarding the impact of COVID-19 on the economy, the consumption and the disposable income. Duyuru • Aug 03
Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020 Gr. Sarantis S.A. announced that they will report first half, 2020 results on Sep 02, 2020 
